Holen Sie sich die Stockscreener-App
14.83
3.89%
-0.60
Handel nachbörslich:
14.81
-0.02
-0.13%
Schlusskurs vom Vortag:
$15.43
Offen:
$15.28
24-Stunden-Volumen:
3.10M
Relative Volume:
0.48
Marktkapitalisierung:
$2.75B
Einnahmen:
$93.95M
Nettoeinkommen (Verlust:
$-129.87M
KGV:
-16.48
EPS:
-0.9
Netto-Cashflow:
$-202.88M
1W Leistung:
-12.76%
1M Leistung:
-19.92%
6M Leistung:
+113.38%
1J Leistung:
+18.64%
1-Tages-Spanne:
$14.34
$15.78
1-Wochen-Bereich:
$14.34
$19.50
52-Wochen-Spanne:
$5.28
$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
14.83 | 2.87B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Bestätigt | Wedbush | Outperform |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-28 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-16 | Eingeleitet | Citigroup | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
How Wave Life Sciences Ltd. (1U5) stock benefits from digital adoption2025 Technical Patterns & Weekly High Conviction Ideas - ulpravda.ru
Will Wave Life Sciences Ltd. stock outperform tech sector in 2025July 2025 Trade Ideas & Step-by-Step Swing Trade Plans - ulpravda.ru
Wave Life Sciences (WVE) Valuation In Focus As Obesity Data, Equity Raise And Conference Updates Draw Attention - simplywall.st
Is Wave Life Sciences Ltd. stock attractive for income investorsPrice Channel Trading & Unlock Patterns Humans Can’t See - ulpravda.ru
Will Wave Life Sciences Ltd. stock maintain growth storyStock Rotation Strategies & Interactive Charts for Smarter Trading - ulpravda.ru
Why Wave Life Sciences Ltd. stock is rated strong buyEx-Dividend Date Alerts & Use Smart Algorithms to Pick Better Stocks - ulpravda.ru
Raymond James raises WAVE Life Sciences stock price target to $26 By Investing.com - Investing.com South Africa
Raymond James raises WAVE Life Sciences stock price target to $26 - Investing.com India
Arrowhead siRNA data in obesity mark POC for adipose delivery - BioCentury
Is Wave Life Sciences’ (WVE) Obesity Bet and Extended Cash Runway Quietly Redefining Its Risk‑Reward Profile? - simplywall.st
Growth or Bubble? Decoding Wave Life Sciences’ Stock Rise - StocksToTrade
Wave Life Sciences stock gains after Arrowhead data supports INHBE mechanism - Investing.com UK
Wave Life Sciences (WVE) Sees Stock Rise Amid Positive Weight Lo - GuruFocus
Wave Life Sciences stock jumps 17% as obesity gene-silencing race heats up - TechStock²
WAVE Life Sciences (NASDAQ:WVE) Shares Gap UpWhat's Next? - MarketBeat
Wave Life Sciences (WVE) Rises Over 18% Following Market Activit - GuruFocus
Is Wave Life Sciences’ Stock a Hidden Gem? - timothysykes.com
Assessing Wave Life Sciences (WVE) Valuation After A Sharp Share Price Rebound - Yahoo Finance
Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Innovator with Over 110% Potential Upside - DirectorsTalk Interviews
Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus - TechStock²
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
San Gabriel Valley Tribune - FinancialContent
Wave Life Sciences (WVE) stock slides 6% — what traders are watching next - TechStock²
Wave Life Sciences stock drops 6% as WVE traders size up next obesity data - TechStock²
WAVE Life Sciences (NASDAQ:WVE) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
HC Wainwright maintains a buy rating on Wave Life Sciences Ltd. (WVE) - MSN
Wave Life Sciences stock tumbles 8.5% in first 2026 session as traders refocus on next WVE-007 readout - ts2.tech
WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 7.1%Here's What Happened - MarketBeat
Wave Life Sciences (WVE) Emerges as Obesity Treatment Contender, Oppenheimer Boosts Price Target - Finviz
Wave Life Sciences (WVE) emerges as obesity treatment contender, Oppenheimer boosts price target - MSN
WAVE Life Sciences Positioned Within Nasdaq Index Biotech Innovation - Kalkine Media
Moody Aldrich Partners LLC Lowers Stock Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
15 Best Stocks Under $25 to Buy Now - Insider Monkey
Wave Life Sciences’ (WVE) RNA Obesity Drug WVE-007 Shows Potential to Match GLP-1 Efficacy Without Muscle Loss - Yahoo Finance
H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE) - Finviz
Mid Cap Stocks To Watch TodayDecember 8th - MarketBeat
Wave Life Sciences Ltd. (WVE) Stock Analysis: Uncovering the 76.93% Upside Potential for Investors - DirectorsTalk Interviews
Voya Investment Management LLC Raises Stock Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
WAVE Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next - ts2.tech
WAVE Life Sciences (STU:1U5) EV-to-OCF : -14.67 (As of Dec. 25, 2025) - GuruFocus
What New Catalysts Are Rewriting the Narrative for Wave Life Sciences? - Yahoo Finance
Behavioral Patterns of WVE and Institutional Flows - Stock Traders Daily
Wave Life Sciences (WVE) Is Up 11.7% After Early WVE-007 Fat-Loss DataWhat's Changed - simplywall.st
Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech
Oppenheimer and Truist lift Wave Life Sciences Ltd. (WVE) price targets after positive trial - MSN
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
Oppenheimer and Truist Lift Wave Life Sciences Ltd. (WVE) Price Targets After Positive Trial - Insider Monkey
WAVE Life Sciences (NASDAQ:WVE) Stock Price Up 9.5%Still a Buy? - MarketBeat
7 Most Promising Gene Editing Stocks According to Analysts - Insider Monkey
Analysts Offer Predictions for WVE Q1 Earnings - MarketBeat
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Wave Life Sciences Ltd-Aktie (WVE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Francis Chris | See Remarks |
Jan 02 '26 |
Sale |
16.03 |
9,375 |
150,260 |
25,000 |
| GSK plc | 10% Owner |
Dec 11 '25 |
Buy |
19.00 |
1,470,000 |
27,930,000 |
18,245,691 |
| Rawcliffe Adrian | Director |
Dec 08 '25 |
Option Exercise |
5.97 |
42,000 |
250,740 |
54,700 |
| Rawcliffe Adrian | Director |
Dec 08 '25 |
Sale |
15.00 |
42,000 |
630,000 |
12,700 |
| Wagner Heidi L | Director |
Dec 08 '25 |
Option Exercise |
5.97 |
14,000 |
83,580 |
51,930 |
| Wagner Heidi L | Director |
Dec 08 '25 |
Sale |
13.50 |
14,000 |
189,000 |
44,930 |
| HENRY CHRISTIAN O | Director |
Dec 08 '25 |
Option Exercise |
5.07 |
87,000 |
440,790 |
54,700 |
| HENRY CHRISTIAN O | Director |
Dec 08 '25 |
Sale |
14.65 |
93,445 |
1,369,324 |
12,700 |
| Tan Aik Na | Director |
Dec 08 '25 |
Option Exercise |
4.85 |
119,230 |
578,270 |
70,400 |
| Tan Aik Na | Director |
Dec 08 '25 |
Sale |
13.58 |
134,218 |
1,823,158 |
25,400 |
0.80%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):